Secular trends of ischaemic heart disease, stroke, and dementia in high-income countries from 1990 to 2017: the Global Burden of Disease Study 2017.
Alzheimer’s disease
Dementia
Disability
Incidence
Ischemic heart disease
Mortality
Prevalence
Public health
Stroke
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
16
11
2020
accepted:
12
04
2021
pubmed:
3
5
2021
medline:
6
1
2022
entrez:
2
5
2021
Statut:
ppublish
Résumé
We assessed secular trends in the burden of ischaemic heart disease (IHD), stroke, and dementia in the Organization for Economic Co-operation and Development (OECD) countries. Using the Global Burden of Disease (GBD) Study 2017, we compared sex-specific and age-standardized rates of disability-adjusted life years (DALY); mortality, incidence, and prevalence of IHD and stroke; and dementia per 100,000 people, in the world, OECD countries, and Canada. From 1990 to 2017, the crude incidence number of IHD, stroke, and dementia increased 52%, 76%, and 113%, respectively. Likewise, the prevalence of IHD (75%), stroke (95%), and dementia (119%) increased worldwide. In addition during the study period, the crude global number of deaths of IHD increased 52%, stroke by 41%, and dementia by 146% (9, 6, and 3 million deaths in 2017, respectively). Despite an increase in the crude number of these diseases, the global age-standardized incidence rate of IHD, stroke, and dementia decreased by -27%, - 11%, and - 5%, respectively. Moreover, there was a decline in their age-standardized DALY rates (- 1.17%, - 1.32%, and - 0.23% per year, respectively) and death rates (- 1.29%, - 1.46%, and - 0.17% per year, respectively), with sharper downward trends in Canada and OECD countries. Almost all trends flattened during the last decade. From 1990 to 2017, the age-standardized burden of IHD, stroke, and dementia decreased, more prominently in OECD countries than the world. However, their rising crude numbers mainly due to population growth and ageing require urgent identification of reversible risk and protective factors.
Sections du résumé
BACKGROUND
BACKGROUND
We assessed secular trends in the burden of ischaemic heart disease (IHD), stroke, and dementia in the Organization for Economic Co-operation and Development (OECD) countries.
METHODS
METHODS
Using the Global Burden of Disease (GBD) Study 2017, we compared sex-specific and age-standardized rates of disability-adjusted life years (DALY); mortality, incidence, and prevalence of IHD and stroke; and dementia per 100,000 people, in the world, OECD countries, and Canada.
RESULTS
RESULTS
From 1990 to 2017, the crude incidence number of IHD, stroke, and dementia increased 52%, 76%, and 113%, respectively. Likewise, the prevalence of IHD (75%), stroke (95%), and dementia (119%) increased worldwide. In addition during the study period, the crude global number of deaths of IHD increased 52%, stroke by 41%, and dementia by 146% (9, 6, and 3 million deaths in 2017, respectively). Despite an increase in the crude number of these diseases, the global age-standardized incidence rate of IHD, stroke, and dementia decreased by -27%, - 11%, and - 5%, respectively. Moreover, there was a decline in their age-standardized DALY rates (- 1.17%, - 1.32%, and - 0.23% per year, respectively) and death rates (- 1.29%, - 1.46%, and - 0.17% per year, respectively), with sharper downward trends in Canada and OECD countries. Almost all trends flattened during the last decade.
CONCLUSIONS
CONCLUSIONS
From 1990 to 2017, the age-standardized burden of IHD, stroke, and dementia decreased, more prominently in OECD countries than the world. However, their rising crude numbers mainly due to population growth and ageing require urgent identification of reversible risk and protective factors.
Identifiants
pubmed: 33934273
doi: 10.1007/s10072-021-05259-2
pii: 10.1007/s10072-021-05259-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
255-264Informations de copyright
© 2021. Fondazione Società Italiana di Neurologia.
Références
GBD 2016 Causes of Death Collaborators (2017) Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the global burden of disease study 2016. Lancet 390(10100):1151–1210
doi: 10.1016/S0140-6736(17)32152-9
Roth GA et al (2017) Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 70(1):1–25
doi: 10.1016/j.jacc.2017.04.052
Avan A et al (2019) Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: an ecological analysis from the global burden of disease study 2017. BMC Med 17(1):1–30
doi: 10.1186/s12916-019-1397-3
GBD 2016 Lifetime Risk of Stroke Collaborators (2018) Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. N Engl J Med 379(25):2429–2437
doi: 10.1056/NEJMoa1804492
Feigin VL et al (2019) Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the global burden of disease study 2016. The Lancet Neurology 18(5):459–480
doi: 10.1016/S1474-4422(18)30499-X
Solomon A et al (2014) Advances in the prevention of Alzheimer’s disease and dementia. J Intern Med 275(3):229–250
doi: 10.1111/joim.12178
Dhamoon MS et al (2007) Risk of myocardial infarction or vascular death after first ischemic stroke: the northern Manhattan study. Stroke 38(6):1752–1758
doi: 10.1161/STROKEAHA.106.480988
Azarpazhooh MR et al (2018) Concomitant vascular and neurodegenerative pathologies double the risk of dementia. Alzheimers Dement 14(2):148–156
doi: 10.1016/j.jalz.2017.07.755
Schneider JA et al (2007) Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69(24):2197–2204
doi: 10.1212/01.wnl.0000271090.28148.24
Kuźma E et al (2018) Stroke and dementia risk: a systematic review and meta-analysis. Alzheimers Dement 14(11):1416–1426
doi: 10.1016/j.jalz.2018.06.3061
Feigin VL et al (2016) Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the global burden of disease study 2013. The Lancet Neurology 15(9):913–924
doi: 10.1016/S1474-4422(16)30073-4
Webster F et al (2011) Organized outpatient care: stroke prevention clinic referrals are associated with reduced mortality after transient ischemic attack and ischemic stroke. Stroke 42(11):3176–3182
doi: 10.1161/STROKEAHA.111.621524
Hachinski V et al (2019) Preventing dementia by preventing stroke: the Berlin manifesto. Alzheimers Dement 15(7):961–984
doi: 10.1016/j.jalz.2019.06.001
Hachinski V (2015) Stroke and potentially preventable dementias proclamation: updated world stroke day proclamation. Am Heart Assoc
Hachinski V (2016) Correction. World stroke organization. Stroke and potentially preventable dementias proclamation: updated world stroke day proclamation. Stroke 47(2):e37
pubmed: 26811332
Hachinski V, W.S. Organization (2015) World stroke day proclamation: updated, Wiley Online Library
Sposato LA et al (2015) Declining incidence of stroke and dementia: coincidence or prevention opportunity? JAMA neurology 72(12):1529–1531
doi: 10.1001/jamaneurol.2015.2816
Cerasuolo JO et al (2019) Evidence of concomitantly increasing stroke and dementia prevalence among those 80 years and older in Ontario, Canada, 2003-04 to 2012-13. Can J Neurol Sci 46(1):105–107
doi: 10.1017/cjn.2018.347
Xie W et al (2019) Cognitive decline before and after incident coronary events. J Am Coll Cardiol 73(24):3041–3050
doi: 10.1016/j.jacc.2019.04.019
Global Burden of Disease Collaborative Network (2018) Global burden of disease study 2017 (GBD 2017) results
World Development Report 1993: Investing in Health. Commun Dis Rep CDR Wkly, 1993. 3(30)
National cancer Institue. Joinpoint Regression Program. Available from: https://surveillance.cancer.gov/joinpoint/
Lerman P (1980) Fitting segmented regression models by grid search. J R Stat Soc: Ser C: Appl Stat 29(1):77–84
Number of Joinpoints — Joinpoint Help System 4.7.0.0. Available from: https://surveillance.cancer.gov/help/joinpoint/setting-parameters/method-and-parameters-tab/number-of-joinpoints
Hachinski V (1992) Preventable senility: a call for action against the. Lancet 340:645
doi: 10.1016/0140-6736(92)92177-H
Ferri CP et al (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366(9503):2112–2117
doi: 10.1016/S0140-6736(05)67889-0
Roehr S et al (2018) Is dementia incidence declining in high-income countries? A systematic review and meta-analysis. Clinical epidemiology 10:1233
doi: 10.2147/CLEP.S163649
Iadecola C et al (2019) Vascular cognitive impairment and dementia: JACC scientific expert panel. J Am Coll Cardiol 73(25):3326–3344
doi: 10.1016/j.jacc.2019.04.034
Feigin VL, Norrving B, Mensah GA (2017) Global burden of stroke. Circ Res 120(3):439–448
doi: 10.1161/CIRCRESAHA.116.308413
Jin Y-P et al (2006) The reciprocal risks of stroke and cognitive impairment in an elderly population. Alzheimers Dement 2(3):171–178
doi: 10.1016/j.jalz.2006.03.006
Universal health coverage (UHC) November 4, 2019]; Available from: https://www.who.int/news-room/fact-sheets/detail/universal-health-coverage-(uhc )
Lozano R et al (2020) Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet 396(10258):1250–1284
doi: 10.1016/S0140-6736(20)30750-9
Lewis M et al (2006) Has Ontario’s stroke system really made a difference. Healthc Q 9(4):50–59
doi: 10.12927/hcq..18407
McAlister FA et al (2013) The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States. Can J Cardiol 29(5):598–605
doi: 10.1016/j.cjca.2012.12.004
Wolf-Maier K et al (2003) Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. Jama 289(18):2363–2369
doi: 10.1001/jama.289.18.2363
Spence JD (2016) Metabolic vitamin B12 deficiency: a missed opportunity to prevent dementia and stroke. Nutr Res 36(2):109–116
doi: 10.1016/j.nutres.2015.10.003
Spence JD, Yi Q, Hankey GJ (2017) B vitamins in stroke prevention: time to reconsider. The Lancet Neurology 16(9):750–760
doi: 10.1016/S1474-4422(17)30180-1
Hackam DG, Spence JD (2018) Decline in the severity of carotid atherosclerosis and associated risk factors from 2002 to 2014. Stroke 49(11):2786–2788
doi: 10.1161/STROKEAHA.118.021445
Smith AD, Refsum H (2016) Homocysteine, B vitamins, and cognitive impairment. Annu Rev Nutr 36(1):211–239
doi: 10.1146/annurev-nutr-071715-050947
Morovatdar N et al (2019) Socioeconomic status and long-term stroke mortality, recurrence and disability in Iran: the Mashhad stroke incidence study. Neuroepidemiology 53(1–2):27–31
doi: 10.1159/000494885
Spence JD, Hackam DG (2010) Treating arteries instead of risk factors: a paradigm change in management of atherosclerosis. Stroke 41(6):1193–1199
doi: 10.1161/STROKEAHA.110.577973